GAM Holding’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,121
| Closed | -$681K | – | 304 |
|
|
2025
Q3 | $681K | Sell |
10,121
-123
| -1% | -$9.73K | 0.04% | 214 |
|
|
2025
Q2 | $894K | Sell |
10,244
-933
| -8% | -$73.1K | 0.06% | 194 |
|
|
2025
Q1 | $763K | Buy |
11,177
+1,647
| +17% | +$134K | 0.06% | 172 |
|
|
2024
Q4 | $741K | Sell |
9,530
-23,609
| -71% | -$1.75M | 0.06% | 164 |
|
|
2024
Q3 | $2.22M | Sell |
33,139
-16,652
| -33% | -$1.37M | 0.18% | 111 |
|
|
2024
Q2 | $5.65M | Sell |
49,791
-7,508
| -13% | -$949K | 0.43% | 70 |
|
|
2024
Q1 | $7.95M | Sell |
57,299
-2,740
| -5% | -$344K | 0.57% | 62 |
|
|
2023
Q4 | $7.45M | Sell |
60,039
-24,975
| -29% | -$2.55M | 0.55% | 65 |
|
|
2023
Q3 | $7.93M | Sell |
85,014
-1,533
| -2% | -$173K | 0.59% | 58 |
|
|
2023
Q2 | $11.1M | Buy |
86,547
+33,264
| +62% | +$4.02M | 0.77% | 39 |
|
|
2023
Q1 | $6.19M | Buy |
53,283
+46,980
| +745% | +$5.26M | 0.43% | 77 |
|
|
2022
Q4 | $714K | Sell |
6,303
-28
| -0.4% | -$3.07K | 0.06% | 180 |
|
|
2022
Q3 | $510K | Sell |
6,331
-3,708
| -37% | -$314K | 0.04% | 187 |
|
|
2022
Q2 | $748K | Sell |
10,039
-5
| -0% | -$456 | 0.05% | 194 |
|
|
2022
Q1 | $1.28M | Sell |
10,044
-3,852
| -28% | -$421K | 0.06% | 188 |
|
|
2021
Q4 | $1.86M | Sell |
13,896
-1,840
| -12% | -$264K | 0.08% | 173 |
|
|
2021
Q3 | $2.15M | Hold |
15,736
| – | – | 0.1% | 172 |
|
|
2021
Q2 | $1.68M | Sell |
15,736
-16
| -0.1% | -$1.54K | 0.07% | 198 |
|
|
2021
Q1 | $1.42M | Buy |
15,752
+11,424
| +264% | +$1.07M | 0.07% | 218 |
|
|
2020
Q4 | $400K | Sell |
4,328
-29,152
| -87% | -$2.6M | 0.02% | 214 |
|
|
2020
Q3 | $3.45M | Buy |
33,480
+36
| +0.1% | +$3.76K | 0.21% | 152 |
|
|
2020
Q2 | $3.39M | Buy |
33,444
+8
| +0% | +$716 | 0.21% | 144 |
|
|
2020
Q1 | $2.25M | Buy |
33,436
+32
| +0.1% | +$1.99K | 0.15% | 176 |
|
|
2019
Q4 | $1.83M | Buy |
33,404
+16
| +0% | +$759 | 0.09% | 239 |
|
|
2019
Q3 | $1.25M | Hold |
33,388
| – | – | 0.05% | 339 |
|
|
2019
Q2 | $1.25M | Hold |
33,388
| – | – | 0.05% | 425 |
|
|
2019
Q1 | $994K | Buy |
+33,388
| New | +$1.17M | 0.04% | 428 |
|
|
2018
Q4 | – | Sell |
-25,028
| Closed | -$895K | – | 811 |
|
|
2018
Q3 | $895K | Buy |
25,028
+5,736
| +30% | +$178K | 0.03% | 500 |
|
|
2018
Q2 | $458K | Buy |
+19,292
| New | +$409K | 0.02% | 683 |
|
|
2017
Q3 | – | Sell |
-18,412
| Closed | -$337K | – | 654 |
|
|
2017
Q2 | $337K | Hold |
18,412
| – | – | 0.01% | 895 |
|
|
2017
Q1 | $390K | Buy |
18,412
+12,560
| +215% | +$245K | 0.01% | 856 |
|
|
2016
Q4 | $87K | Buy |
+5,852
| New | +$104K | ﹤0.01% | 995 |
|
|
2016
Q3 | – | Sell |
-184,680
| Closed | -$3.66M | – | 950 |
|
|
2016
Q2 | $3.66M | Sell |
184,680
-95,160
| -34% | -$1.62M | 0.06% | 366 |
|
|
2016
Q1 | $4.75M | Buy |
+279,840
| New | +$4.67M | 0.08% | 283 |
|
Other funds holding DXCM
JSC
GAM Holding's DXCM Position: Q4 2025 in Review
GAM Holding sold out of DexCom (DXCM) in Q4 2025, closing a stake of 10,121 shares — an estimated $681K sold.
GAM Holding first reported a position in DXCM in Q1 2016 and held it in 34 quarters. The position peaked at $11.1M in Q2 2023. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.
- GAM Holding reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
- GAM Holding sold 10,121 DexCom shares in Q4 2025, an estimated $681K.
- GAM Holding first reported a position in DexCom in Q1 2016 and held it in 34 quarters.
- GAM Holding's DexCom position peaked at $11.1M in Q2 2023.
- 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.
Based on GAM Holding's 13F filing for Q4 2025, filed 17 Feb 2026.